Cross Jessica A, Cole Brian J, Spatny Kaylan P, Sundman Emily, Romeo Anthony A, Nicholson Greg P, Wagner Bettina, Fortier Lisa A
Department of Clinical Sciences, Cornell University, Ithaca, New York, USA.
Department of Orthopedics, Rush University Medical Center, Chicago, Illinois, USA
Am J Sports Med. 2015 Dec;43(12):2898-906. doi: 10.1177/0363546515608157. Epub 2015 Oct 12.
The optimal platelet-rich plasma (PRP) for treatment of supraspinatus tendinopathy has not been determined.
To evaluate the effect of low- versus high-leukocyte concentrated PRP products on catabolic and anabolic mediators of matrix metabolism in diseased rotator cuff tendons.
Controlled laboratory study.
Diseased supraspinatus tendons were treated with PRP made by use of 2 commercial systems: Arthrex Autologous Conditioned Plasma Double Syringe System (L(lo) PRP) and Biomet GPS III Mini Platelet Concentrate System (L(hi) PRP). Tendon explants were placed in 6-well plates and cultured in L(lo) PRP, L(hi) PRP, or control media (Dulbecco's Modified Eagle Medium + 10% fetal bovine serum) for 96 hours. Tendons were processed for hematoxylin-eosin histologic results and were scored with the modified Bonar scale. Group 1 tendons were defined as moderate tendinopathy (Bonar score <3); group 2 tendons were assessed as severely affected (Bonar score = 3). Transforming growth factor β-1 (TGFβ-1), interleukin-1β (IL-1β), interleukin-1 receptor antagonist (IL-1Ra), interleukin-6 (IL-6), interleukin-8 (IL-8), and matrix metalloproteinase-9 (MMP-9) concentrations in PRP media were measured by use of enzyme-linked immunosorbent assay after 96 hours of culture with diseased tendon. Tendon messenger RNA expression of collagen type I (COL1A1), collagen type III (COL3A1), cartilage oligomeric matrix protein (COMP), MMP-9, MMP-13, and IL-1β was measured with real-time quantitative polymerase chain reaction.
Leukocytes and platelets were significantly more concentrated in L(hi) PRP compared with L(lo) PRP. Increased IL-1β was present in L(hi) PRP after culture with group 1 tendons. IL-6 was increased in L(hi) PRP after culture with group 2 tendons. Both TGFβ-1 and MMP-9 were increased in L(hi) PRP after culture with either tendon group. In L(lo) PRP cultures, IL-1Ra:IL-1β in PRP used as media and COL1A1:COL3A1 gene expression were increased for group 1 tendon cultures. Gene expression of MMP-9 and IL-1β was increased in group 2 tendons cultured in L(lo) PRP. There was no significant difference in the expression of MMP-13 or COMP in either group of tendons cultured in L(lo) PRP or L(hi) PRP.
L(lo) PRP promotes normal collagen matrix synthesis and decreases cytokines associated with matrix degradation and inflammation to a greater extent than does L(hi) PRP in moderately degenerative tendons. In severely degenerative tendons, neither PRP preparation enhanced matrix synthesis.
L(lo) PRP may promote healing in moderately degenerative rotator cuff tendons.
治疗冈上肌腱病的最佳富血小板血浆(PRP)尚未确定。
评估低白细胞与高白细胞浓缩PRP产品对病变肩袖肌腱中基质代谢的分解代谢和合成代谢介质的影响。
对照实验室研究。
用两种商业系统制备的PRP治疗病变的冈上肌腱:Arthrex自体条件血浆双注射器系统(低白细胞PRP)和Biomet GPS III微型血小板浓缩系统(高白细胞PRP)。将肌腱外植体置于6孔板中,在低白细胞PRP、高白细胞PRP或对照培养基(杜氏改良 Eagle培养基+10%胎牛血清)中培养96小时。对肌腱进行苏木精-伊红组织学检查,并采用改良的博纳尔评分法进行评分。第1组肌腱定义为中度肌腱病(博纳尔评分<3);第2组肌腱评估为严重受累(博纳尔评分=3)。在与病变肌腱培养96小时后,采用酶联免疫吸附测定法测量PRP培养基中转化生长因子β-1(TGFβ-1)、白细胞介素-1β(IL-1β)、白细胞介素-1受体拮抗剂(IL-1Ra)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)和基质金属蛋白酶-9(MMP-9)的浓度。用实时定量聚合酶链反应测量肌腱中I型胶原(COL1A1)、III型胶原(COL3A1)、软骨寡聚基质蛋白(COMP)、MMP-9、MMP-13和IL-1β的信使核糖核酸表达。
与低白细胞PRP相比,高白细胞PRP中的白细胞和血小板浓度显著更高。第1组肌腱培养后,高白细胞PRP中IL-1β增加。第2组肌腱培养后,高白细胞PRP中IL-6增加。两组肌腱培养后,高白细胞PRP中TGFβ-1和MMP-9均增加。在低白细胞PRP培养中,第1组肌腱培养的PRP用作培养基时IL-1Ra:IL-1β以及COL1A1:COL3A1基因表达增加。在低白细胞PRP中培养的第2组肌腱中,MMP-9和IL-1β的基因表达增加。在低白细胞PRP或高白细胞PRP中培养的两组肌腱中,MMP-13或COMP的表达无显著差异。
在中度退变的肌腱中,低白细胞PRP比高白细胞PRP更能促进正常胶原基质合成,并在更大程度上降低与基质降解和炎症相关的细胞因子。在严重退变的肌腱中,两种PRP制剂均未增强基质合成。
低白细胞PRP可能促进中度退变的肩袖肌腱愈合。